APA

van Rees Vellinga T. E., Peters R. J. G., Yusuf S., Afzal R., Chrolavicius S., O'Donnell M., Mehta S. R., Pluta W., Sacha J. & Eikelboom J. W. (20110208). Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial. : American heart journal.

Chicago

van Rees Vellinga Tjeerd E, Peters Ron J G, Yusuf Salim, Afzal Rizwan, Chrolavicius Susan, O'Donnell Martin, Mehta Shamir R, Pluta Wadysław, Sacha Jerzy and Eikelboom John W. 20110208. Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial. : American heart journal.

Harvard

van Rees Vellinga T. E., Peters R. J. G., Yusuf S., Afzal R., Chrolavicius S., O'Donnell M., Mehta S. R., Pluta W., Sacha J. and Eikelboom J. W. (20110208). Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial. : American heart journal.

MLA

van Rees Vellinga Tjeerd E, Peters Ron J G, Yusuf Salim, Afzal Rizwan, Chrolavicius Susan, O'Donnell Martin, Mehta Shamir R, Pluta Wadysław, Sacha Jerzy and Eikelboom John W. Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial. : American heart journal. 20110208.